Vue transversale globale
Toutes les maladies
Un même point d’entrée pour les études cliniques, les découvertes scientifiques, les publications et les pistes exploratoires présentes dans Biomedical Watch.
Périmètre
Filtrer toute la vue
Chaque choix s’applique immédiatement aux quatre sections. Le filtre « type de SEP » n’apparaît que lorsque la sclérose en plaques est sélectionnée.
10934 résultats correspondants
· 41 visibles sur cette page
dans le périmètre Toutes les maladies
Niveau clinique
Études et traitements 6003
Interventions, programmes et essais cliniques rattachés au périmètre sélectionné.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Vagus nerve stimulation NCT06237595 · Vagus Nerve Stimulation in Fibromyalgia | Myopathies | À vérifier | Non applicable | COMPLETED | Vagus nerve stimulation is thought to reduce sympathetic nerve outflow and… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:34 | Détail |
| Development of a Therapeutic Endpoint in Pediatric Rheumatologic Cond… NCT04833465 · NCT04833465 | Lupus | Traitement symptomatique | À vérifier | RECRUITING | The overarching goal of this study is the development of a physiologic end… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:33 | Détail |
| Ianalumab NCT05624749 · Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patien… | Lupus | À vérifier | Phase 3 | ACTIVE_NOT_RECRUITING | The purpose of this study is to evaluate long-term safety and tolerability… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:33 | Détail |
| Ianalumab NCT05639114 · Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care T… | Lupus | À vérifier | Phase 3 | ACTIVE_NOT_RECRUITING | The purpose of this study is to evaluate long-term safety and tolerability… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:32 | Détail |
| LMY-922 NCT07729995 · BAFF CAR-T Cells (LMY-922) for Treatment of Refractory Autoimmune Disease | Lupus | Immunomodulation · Thérapie cellulaire | Phase 1 | NOT_YET_RECRUITING | Therapy with chimeric antigen receptor T (CAR-T) cells has demonstrated ac… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:32 | Détail |
| Medi-546 NCT04877691 · Tulip SC — Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythe… | Lupus | À vérifier | Phase 3 | ACTIVE_NOT_RECRUITING | The purpose of this study is evaluating the efficacy and safety of SC anti… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:32 | Détail |
| Cenerimod NCT07201129 · LUMIOS — A Research Trial to Assess if Cenerimod is Efficacious and Safe to Trea… | Lupus | Thérapie génique | Phase 3 | RECRUITING | The goal of this clinical trial is to learn if cenerimod, on top of regula… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:31 | Détail |
| Cenerimod 0.5 mg NCT03742037 · Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subj… | Lupus | À vérifier | Phase 2 | COMPLETED | The purpose of the study is to assess the efficacy and safety of 4 doses o… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:31 | Détail |
| Cenerimod 4 mg NCT07266090 · A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamic… | Lupus | À vérifier | Phase 2 | ACTIVE_NOT_RECRUITING | The purpose of the study is to assess the efficacy and safety of 4 doses o… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:31 | Détail |
| SLEIGH — Systemic Lupus Erythematosus in Gullah Health NCT00756769 · NCT00756769 | Lupus | Ralentissement de la progression · Traitement symptomatique | À vérifier | RECRUITING | Systemic lupus erythematosus (SLE) is an autoimmune disease characterized… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:31 | Détail |
| Surovatamig NCT07201558 · ASSURO — Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA… | Lupus | À vérifier | Phase 1 | RECRUITING | This open-label, Phase I study will assess the safety and tolerability of… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:31 | Détail |
| Afimetoran NCT04895696 · A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo i… | Lupus | À vérifier | Phase 2 | ACTIVE_NOT_RECRUITING | The purpose of this study is to evaluate the effectiveness, safety and tol… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:30 | Détail |
| Anifrolumab NCT05138133 · IRIS — Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative… | Lupus | À vérifier | Phase 3 | ACTIVE_NOT_RECRUITING | This is an observational study, in which the main research question is to… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:30 | Détail |
| Anti-CD19 CAR PBL NCT00068003 · Harvesting Cells for Experimental Cancer Treatments | Cancer | À vérifier | À vérifier | ENROLLING_BY_INVITATION | Background: The NCI Surgery Branch has developed experimental therapies th… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:26 | Détail |
| A Self-management Based Survivorship Intervention for Chinese Cancer… NCT05534386 · NCT05534386 | Cancer | Traitement symptomatique | Non applicable | RECRUITING | This study, using a sequential multiple assessment randomized controlled t… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:26 | Détail |
| Estrogen NCT05562518 · GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in br… | Cancer | À vérifier | Phase 4 | COMPLETED | In this prospective active-controlled randomized trial the investigators w… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:26 | Détail |
| Multiple Level Intertransverse Process Block NCT07763756 · Single vs Multiple Injection Intertransverse Process Block in Breast Cancer Surg… | Cancer | À vérifier | Non applicable | NOT_YET_RECRUITING | This randomized clinical trial aims to evaluate and compare the analgesic… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:26 | Détail |
| Prospective Evaluation of High Resolution Dual Energy Computed Tomogr… NCT04431024 · Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imagi… | Cancer | Thérapie génique | À vérifier | RECRUITING | Background: A germline mutation is a change to a person s genes that is ca… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:26 | Détail |
| Real World Asparaginase Therapy Toxicity NCT07008027 · NCT07008027 | Cancer | Thérapie génique | À vérifier | NOT_YET_RECRUITING | This research study is being done to learn more about the short term and l… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:26 | Détail |
| Venetoclax NCT07762508 · A Prospective Single-Arm Study of VABu Conditioning Regimen in Allo-HSCT for Low… | Cancer | Thérapie cellulaire · Thérapie génique | Non applicable | NOT_YET_RECRUITING | This study evaluates the effectiveness and safety of a new conditioning re… À vérifier | ClinicalTrials.gov 2026-08-13 14:28:26 | Détail |
Découverte scientifique
Recherches et trouvailles 21
Projets précliniques, publications émergentes et programmes de recherche suivis dans le pipeline.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| 4-octyl itaconate et dérivés Dérivés de l’itaconate — neuroinflammation | Sclérose latérale amyotrophique | Neuroprotection · Immunomodulation | Découverte fondamentale | Exploratoire | Modulation immunométabolique de la microglie · NRF2 / inflammation microgl… Piste mécanistique visant à reprogrammer la réponse inflammatoire de la microglie. Le lien avec la SLA reste exploratoi… | Revue scientifique 2024-07-01 | Détail |
Bibliographie
Publications 4910
Références bibliographiques de la base locale et accès à leur source originale.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| A comparative study of the role of crocin and sitagliptin in attenuat… Standard Oral Hypoglycemic Agent · PMID 31394428 | Maladie rénale chronique | Ralentissement de la progression · Immunomodulation | Publication | PubMed | Voir la publication source Type 1 diabetes mellitus (T1DM) describes a complex group of metabolic disorders associated with elevated blood glucose… | Environmental toxicology and pharmacology 2026-11-15 04:38:02 | Source |
| Anti diabetic effect of Achyranthes rubrofusca leaf extracts on allox… Standard Oral Hypoglycemic Agent · PMID 21454169 | Maladie rénale chronique | À vérifier | Publication | PubMed | Voir la publication source The aqueous and ethanolic extracts of Achyranthes rubrofuca leaves (AR) were studied for their hypoglycemic activity. T… | Pakistan journal of pharmaceutical sciences 2026-11-15 04:38:02 | Source |
| Antihyperglycemic and hypolipidemic activities of Setaria italica see… Standard Oral Hypoglycemic Agent · PMID 20869855 | Maladie rénale chronique | À vérifier | Publication | PubMed | Voir la publication source Setaria italica is commonly known as Foxtail millet. In India it is chiefly cultivated in Andhra Pradesh and Tamilnadu.… | Pathophysiology : the official journal of the Internat… 2026-11-15 04:38:02 | Source |
| Enhancing neoadjuvant immunotherapy for locally advanced rectal cance… HJB647 high dose · PMID 42860120 | Cancer | Immunomodulation | Publication | PubMed | Voir la publication source Conventional surgery for locally advanced rectal cancer (LARC) faces challenges including difficult sphincter preservat… | Biomaterials 2026-11-15 04:37:50 | Source |
| Oxygen-vacancy-rich LDH sonosensitizers potentiate narrow-spectrum an… HJB647 high dose · PMID 42910182 | Insuffisance cardiaque | Neuroprotection · Immunomodulation · Thérapie génique | Publication | PubMed | Voir la publication source Mixed bacterial infections, including Gram-positive and Gram-negative pathogens, remain a major global health concern.… | Bioactive materials 2026-11-15 04:37:50 | Source |
| Respiratory Support With Nasal High Flow Reduces Opioid Requirements… HJB647 high dose · PMID 42699223 | Insuffisance cardiaque | À vérifier | Publication | PubMed | Voir la publication source Nasal high flow (NHF) improves oxygenation, reduces the work of breathing, and stabilizes ventilation. In endoscopic re… | DEN open 2026-11-15 04:37:50 | Source |
| Feasibility of a Deep-Learning Model for Objective Visualization-Qual… Lithotripsy · PMID 42898633 | Maladie coronarienne | À vérifier | Publication | PubMed | Voir la publication source During peroral cholangioscopy-guided electrohydraulic lithotripsy (EHL), stone fragmentation obscures the visual field… | DEN open 2026-11-15 04:37:45 | Source |
| Impact of calcium burden, lesion preparation, and lithotripsy on sten… Lithotripsy · PMID 42777787 | Maladie coronarienne | À vérifier | Publication | PubMed | Voir la publication source Stent underexpansion in severely calcified coronary lesions increases the risk of target vessel failure. Intravascular… | International journal of cardiology 2026-11-15 04:37:45 | Source |
| Intravascular lithotripsy for calcific stenosis of the abdominal aort… Lithotripsy · PMID 43001236 | Maladie coronarienne | À vérifier | Publication | PubMed | Voir la publication source Takayasu arteritis is a rare large-vessel vasculitis that predominantly affects the aorta and its major branches. Altho… | Journal of vascular surgery cases and innovative techn… 2026-11-15 04:37:45 | Source |
| Placenta-derived mesenchymal stem cells for prenatal myelomeningocele… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… | Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… | Thérapie cellulaire | Publication | PubMed | Voir la publication source Résumé non disponible dans la base locale. | Annals of translational medicine 2026-11-15 04:37:41 | Source |
| Synovial Biomarker Modulation and Clinical Response to Umbilical Cord… cultured allogeneic adult umbilical cord or placental derived mesenchymal stem cells · PMID 42… | Sclérose en plaques · Sclérose latérale amyotrophique · Sclérose laté… | Immunomodulation · Thérapie cellulaire | Publication | PubMed | Voir la publication source ObjectiveUmbilical cord-derived mesenchymal stromal cells (UC-MSCs) are a promising treatment for knee osteoarthritis (… | Cartilage 2026-11-15 04:37:41 | Source |
| Design, synthesis, and biological evaluation of 1H-1,2,4-triazole-3-c… B007 · PMID 42142713 | Insuffisance cardiaque | À vérifier | Publication | PubMed | Voir la publication source The apelin receptor (AplnR) is a prominent peptide-binding Class A G protein-coupled receptor (GPCR) involved in the re… | Bioorganic & medicinal chemistry letters 2026-11-15 04:37:34 | Source |
| Programmable Nanobody-Targeting Chimeras Enable Intracellular Viral P… B007 · PMID 42467897 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source Chronic hepatitis B virus (HBV) infection remains a major global health challenge, largely because current antiviral th… | Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026-11-15 04:37:34 | Source |
| Understanding the Selectivity of Selective Oxidation of Propane to Ac… B007 · PMID 41768713 | Myasthénie | À vérifier | Publication | PubMed | Voir la publication source In this work, we have performed a quantum chemical investigation for the selective oxidation of propane toward acrylic… | ACS omega 2026-11-15 04:37:34 | Source |
| Comparative efficacy and acceptability of antidepressants in the long… Milnacipran · PMID 43008763 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source Major depressive disorder carries high risks of relapse and chronicity, necessitating treatments that achieve and maint… | The lancet. Psychiatry 2026-11-15 04:37:30 | Source |
| Polysubstance-Induced Vasoplegia Managed with Venoarterial Extracorpo… Milnacipran · PMID 43014364 | Myopathies | À vérifier | Publication | PubMed | Voir la publication source While the use of venoarterial extracorporeal membrane oxygenation (VA-ECMO) becomes increasingly commonplace in overdos… | Clinical practice and cases in emergency medicine 2026-11-15 04:37:30 | Source |
| Early Outcome of a Single Peri-Tendinous Hyaluronic Acid Injection fo… Sodium hyaluronate with mannitol (Ostenil Tendon) · PMID 33132010 | Myopathies | Traitement symptomatique | Publication | PubMed | Voir la publication source The aim of this study was to evaluate the efficacy and safety of a single, peri-tendinous injection of hyaluronic acid… | Foot (Edinburgh, Scotland) 2026-11-15 04:37:29 | Source |
| Engineered stem cell-derived CD16-enhanced universal NKT cells improv… Tafasitamab and NK cells · PMID 43008138 | Cancer | Immunomodulation · Thérapie cellulaire | Publication | PubMed | Voir la publication source Monoclonal antibody (mAb)-based therapies have revolutionized cancer treatment; however, their clinical efficacy is oft… | Cancer immunology research 2026-11-15 04:37:24 | Source |
| Precision Fc remodeling via glycosylation-competent CHO display enabl… Tafasitamab and NK cells · PMID 41923108 | Cancer | Immunomodulation | Publication | PubMed | Voir la publication source BACKGROUND: Improving tumor cell clearance by therapeutic antibodies remains a translational bottleneck because wild-ty… | Journal of biological engineering 2026-11-15 04:37:24 | Source |
| The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural kil… Tafasitamab and NK cells · PMID 23277329 | Lupus | À vérifier | Publication | PubMed | Voir la publication source Résumé non disponible dans la base locale. | Leukemia 2026-11-15 04:37:24 | Source |
Exploration — prudence
Pistes exploratoires 0
Rapprochements mécanistiques et hypothèses de recherche : ils ne constituent pas une preuve d’efficacité ni une recommandation thérapeutique.
Hypothèses non validéesÀ confirmer par des travaux précliniques, cliniques et une revue scientifique indépendante.
| Molécule / élément | Maladie / population | Objectif | Phase / stade | Statut / preuve | Mécanisme / résumé | Source | Détail |
|---|---|---|---|---|---|---|---|
| Aucune piste exploratoire ne correspond aux filtres. | |||||||